{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:17:12Z","timestamp":1779891432056,"version":"3.53.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Mach Intell"],"DOI":"10.1038\/s42256-022-00527-y","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T16:14:26Z","timestamp":1663258466000},"page":"739-748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Accelerated rational PROTAC design via deep learning and molecular simulations"],"prefix":"10.1038","volume":"4","author":[{"given":"Shuangjia","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youhai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6782-2813","authenticated-orcid":false,"given":"Yuedong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"527_CR1","doi-asserted-by":"publisher","first-page":"8554","DOI":"10.1073\/pnas.141230798","volume":"98","author":"KM Sakamoto","year":"2001","unstructured":"Sakamoto, K. M. et al. Protacs: chimeric molecules that target proteins to the Skp1\u2013cullin\u2013F box complex for ubiquitination and degradation. Proc. Natl Acad. Sci. U. S. A. 98, 8554\u20138559 (2001).","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"527_CR2","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/nchembio.1887","volume":"11","author":"RJ Deshaies","year":"2015","unstructured":"Deshaies, R. J. Prime time for PROTACs. Nat. Chem. Biol. 11, 634\u2013635 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"527_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer. 21, 1\u201317 (2021).","journal-title":"Nat. Rev. Cancer."},{"key":"527_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ddtec.2019.01.002","volume":"31","author":"M Pettersson","year":"2019","unstructured":"Pettersson, M. & Crews, C. M. PROteolysis TArgeting Chimeras (PROTACs)\u2014past, present and future. Drug Discov. Today Technol. 31, 15\u201327 (2019).","journal-title":"Drug Discov. Today Technol."},{"key":"527_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrd.2016.211","volume":"16","author":"AC Lai","year":"2017","unstructured":"Lai, A. C. & Crews, C. M. Induced protein degradation: an emerging drug discovery paradigm. Nat. Rev. Drug Discov. 16, 101\u2013114 (2017).","journal-title":"Nat. Rev. Drug Discov."},{"key":"527_CR6","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","volume":"36","author":"L Bai","year":"2019","unstructured":"Bai, L. et al. A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo. Cancer Cell 36, 498\u2013511. e417 (2019).","journal-title":"Cancer Cell"},{"key":"527_CR7","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1021\/acs.jmedchem.0c02234","volume":"64","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. Design and synthesis of EZH2-based PROTACs to degrade the PRC2 complex for targeting the noncatalytic activity of EZH2. J. Med. Chem. 64, 2829\u20132848 (2021).","journal-title":"J. Med. Chem."},{"key":"527_CR8","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.jmedchem.8b01631","volume":"62","author":"X Han","year":"2019","unstructured":"Han, X. et al. Discovery of ARD-69 as a highly potent proteolysis targeting chimera (PROTAC) degrader of androgen receptor (AR) for the treatment of prostate cancer. J. Med. Chem. 62, 941\u2013964 (2019).","journal-title":"J. Med. Chem."},{"key":"527_CR9","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.jmedchem.8b01413","volume":"62","author":"V Zoppi","year":"2018","unstructured":"Zoppi, V. et al. Iterative design and optimization of initially inactive proteolysis targeting chimeras (PROTACs) identify VZ185 as a potent, fast, and selective von Hippel\u2013Lindau (VHL) based dual degrader probe of BRD9 and BRD7. J. Med. Chem. 62, 699\u2013726 (2018).","journal-title":"J. Med. Chem."},{"key":"527_CR10","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41589-018-0055-y","volume":"14","author":"RP Nowak","year":"2018","unstructured":"Nowak, R. P. et al. Plasticity in binding confers selectivity in ligand-induced protein degradation. Nat. Chem. Biol. 14, 706\u2013714 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"527_CR11","doi-asserted-by":"publisher","first-page":"8042","DOI":"10.1021\/acs.jmedchem.1c00482","volume":"64","author":"TA Bemis","year":"2021","unstructured":"Bemis, T. A., La Clair, J. J. & Burkart, M. D. Unraveling the role of linker design in proteolysis targeting chimeras. J. Med. Chem. 64, 8042\u20138052 (2021).","journal-title":"J. Med. Chem."},{"key":"527_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08027-7","volume":"10","author":"BE Smith","year":"2019","unstructured":"Smith, B. E. et al. Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase. Nat. Commun. 10, 131 (2019).","journal-title":"Nat. Commun."},{"key":"527_CR13","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.bmcl.2019.04.030","volume":"29","author":"SD Edmondson","year":"2019","unstructured":"Edmondson, S. D., Yang, B. & Fallan, C. Proteolysis targeting chimeras (PROTACs) in \u2018beyond rule-of-five\u2019chemical space: recent progress and future challenges. Bioorg. Med. Chem. Lett. 29, 1555\u20131564 (2019).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"527_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41587-021-01173-2","volume":"40","author":"K Garber","year":"2022","unstructured":"Garber, K. The PROTAC gold rush. Nat. Biotechnol. 40, 12\u201316 (2022).","journal-title":"Nat. Biotechnol."},{"key":"527_CR15","doi-asserted-by":"publisher","first-page":"672267","DOI":"10.3389\/fchem.2021.672267","volume":"9","author":"C Cecchini","year":"2021","unstructured":"Cecchini, C., Pannilunghi, S., Tardy, S. & Scapozza, L. From conception to development: investigating PROTACs features for improved cell permeability and successful protein degradation. Front. Chem. 9, 672267 (2021).","journal-title":"Front. Chem."},{"key":"527_CR16","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","volume":"18","author":"J Vamathevan","year":"2019","unstructured":"Vamathevan, J. et al. Applications of machine learning in drug discovery and development. Nat. Rev. Drug Discov. 18, 463\u2013477 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"527_CR17","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","volume":"18","author":"S Ekins","year":"2019","unstructured":"Ekins, S. et al. Exploiting machine learning for end-to-end drug discovery and development. Nat. Mater. 18, 435\u2013441 (2019).","journal-title":"Nat. Mater."},{"key":"527_CR18","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1021\/acscentsci.7b00512","volume":"4","author":"MHS Segler","year":"2018","unstructured":"Segler, M. H. S., Kogej, T., Tyrchan, C. & Waller, M. P. Generating focused molecule libraries for drug discovery with recurrent neural networks. ACS Cent. Sci. 4, 120\u2013131 (2018).","journal-title":"ACS Cent. Sci."},{"key":"527_CR19","doi-asserted-by":"publisher","first-page":"1700111","DOI":"10.1002\/minf.201700111","volume":"37","author":"A Gupta","year":"2018","unstructured":"Gupta, A. et al. Generative recurrent networks for de novo drug design. Mol. Inf. 37, 1700111 (2018).","journal-title":"Mol. Inf."},{"key":"527_CR20","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s42256-020-0174-5","volume":"2","author":"P-C Kotsias","year":"2020","unstructured":"Kotsias, P.-C. et al. Direct steering of de novo molecular generation with descriptor conditional recurrent neural networks. Nat. Mach. Intell. 2, 254\u2013265 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"527_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13321-019-0328-9","volume":"11","author":"S Zheng","year":"2019","unstructured":"Zheng, S. et al. QBMG: quasi-biogenic molecule generator with deep recurrent neural network. J Cheminform 11, 5 (2019).","journal-title":"J Cheminform"},{"key":"527_CR22","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1021\/acs.jcim.0c01416","volume":"61","author":"J Wang","year":"2021","unstructured":"Wang, J., Zheng, S., Chen, J. & Yang, Y. Meta learning for low-resource molecular optimization. J. Chem. Inf. Model. 61, 1627\u20131636 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-021-00565-5","volume":"13","author":"S Zheng","year":"2021","unstructured":"Zheng, S. et al. Deep scaffold hopping with multimodal transformer neural networks. J Cheminform 13, 1\u201315 (2021).","journal-title":"J Cheminform"},{"key":"527_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","volume":"4","author":"R Gomez-Bombarelli","year":"2018","unstructured":"Gomez-Bombarelli, R. et al. Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent. Sci. 4, 268\u2013276 (2018).","journal-title":"ACS Cent. Sci."},{"key":"527_CR25","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1021\/acs.jcim.8b00706","volume":"59","author":"M Skalic","year":"2019","unstructured":"Skalic, M., Jimenez, J., Sabbadin, D. & De Fabritiis, G. Shape-based generative modeling for de novo drug design. J. Chem. Inf. Model. 59, 1205\u20131214 (2019).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR26","unstructured":"De Cao, N. & Kipf, T. MolGAN: an implicit generative model for small molecular graphs. Preprint at https:\/\/arxiv.org\/abs\/1805.11973 (2018)."},{"key":"527_CR27","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1021\/acs.molpharmaceut.7b00346","volume":"14","author":"A Kadurin","year":"2017","unstructured":"Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A. & Zhavoronkov, A. druGAN: an advanced generative adversarial autoencoder model for de novo generation of new molecules with desired molecular properties in silico. Mol Pharm 14, 3098\u20133104 (2017).","journal-title":"Mol Pharm"},{"key":"527_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1021\/acs.accounts.0c00699","volume":"54","author":"WP Walters","year":"2021","unstructured":"Walters, W. P. & Barzilay, R. Applications of deep learning in molecule generation and molecular property prediction. Acc. Chem. Res. 54, 263\u2013270 (2021).","journal-title":"Acc. Chem. Res."},{"key":"527_CR29","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","volume":"37","author":"A Zhavoronkov","year":"2019","unstructured":"Zhavoronkov, A. et al. Deep learning enables rapid identification of potent DDR1 kinase inhibitors. Nat. Biotechnol. 37, 1038\u20131040 (2019).","journal-title":"Nat. Biotechnol."},{"key":"527_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41551-021-00689-x","volume":"5","author":"P Das","year":"2021","unstructured":"Das, P. et al. Accelerated antimicrobial discovery via deep generative models and molecular dynamics simulations. Nat. Biomed. Eng. 5, 613\u2013623 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"527_CR31","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41551-021-00699-9","volume":"5","author":"DM Mason","year":"2021","unstructured":"Mason, D. M. et al. Optimization of therapeutic antibodies by predicting antigen specificity from antibody sequence via deep learning. Nat. Biomed. Eng. 5, 600\u2013612 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"527_CR32","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1021\/acs.jcim.9b01120","volume":"60","author":"F Imrie","year":"2020","unstructured":"Imrie, F., Bradley, A. R., van der Schaar, M. & Deane, C. M. Deep generative models for 3D linker design. J. Chem. Inf. Model. 60, 1983\u20131995 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR33","doi-asserted-by":"publisher","first-page":"8312","DOI":"10.1039\/D0SC03126G","volume":"11","author":"Y Yang","year":"2020","unstructured":"Yang, Y. et al. SyntaLinker: automatic fragment linking with deep conditional transformer neural networks. Chem. Sci. 11, 8312\u20138322 (2020).","journal-title":"Chem. Sci."},{"key":"527_CR34","doi-asserted-by":"publisher","first-page":"D1381","DOI":"10.1093\/nar\/gkaa807","volume":"49","author":"G Weng","year":"2021","unstructured":"Weng, G. et al. PROTAC-DB: an online database of PROTACs. Nucleic Acids Res. 49, D1381\u2013D1387 (2021).","journal-title":"Nucleic Acids Res."},{"key":"527_CR35","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1021\/acscentsci.6b00367","volume":"3","author":"H Altae-Tran","year":"2017","unstructured":"Altae-Tran, H., Ramsundar, B., Pappu, A. S. & Pande, V. Low data drug discovery with one-shot learning. ACS Cent Sci 3, 283\u2013293 (2017).","journal-title":"ACS Cent Sci"},{"key":"527_CR36","unstructured":"Vaswani, A. et al. Attention is all you need. In Guyon, I. et al. (eds). Advances in Neural Information Processing Systems, 30 (2017). https:\/\/proceedings.neurips.cc\/paper\/2017\/file\/3f5ee243547dee91fbd053c1c4a845aa-Paper.pdf"},{"key":"527_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-019-0393-0","volume":"11","author":"J Ar\u00fas-Pous","year":"2019","unstructured":"Ar\u00fas-Pous, J. et al. Randomized SMILES strings improve the quality of molecular generative models. J. Cheminform. 11, 1\u201313 (2019).","journal-title":"J. Cheminform."},{"key":"527_CR38","unstructured":"Wang, Z. et al. Sample efficient actor-critic with experience replay. Preprint at https:\/\/arxiv.org\/abs\/1611.01224 (2016)."},{"key":"527_CR39","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13321-017-0235-x","volume":"9","author":"M Olivecrona","year":"2017","unstructured":"Olivecrona, M., Blaschke, T., Engkvist, O. & Chen, H. Molecular de-novo design through deep reinforcement learning. J Cheminform 9, 48 (2017).","journal-title":"J Cheminform"},{"key":"527_CR40","unstructured":"ClinicalTrials.gov database, https:\/\/clinicaltrials.gov\/"},{"key":"527_CR41","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.molcel.2017.06.004","volume":"67","author":"GE Winter","year":"2017","unstructured":"Winter, G. E. et al. BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment. Mol. Cell 67, 5\u201318 (2017). e19.","journal-title":"Mol. Cell"},{"key":"527_CR42","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742\u2013754 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR43","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","volume":"53","author":"JB Baell","year":"2010","unstructured":"Baell, J. B. & Holloway, G. A. New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. J. Med. Chem. 53, 2719\u20132740 (2010).","journal-title":"J. Med. Chem."},{"key":"527_CR44","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1021\/ci9803381","volume":"39","author":"D Butina","year":"1999","unstructured":"Butina, D. Unsupervised data base clustering based on daylight\u2019s fingerprint and Tanimoto similarity: a fast and automated way to cluster small and large data sets. J. Chem. Inf. Comput. Sci. 39, 747\u2013750 (1999).","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"527_CR45","doi-asserted-by":"publisher","first-page":"4894","DOI":"10.1021\/acs.jcim.0c00589","volume":"60","author":"D Zaidman","year":"2020","unstructured":"Zaidman, D., Prilusky, J. & London, N. PRosettaC: Rosetta based modeling of PROTAC mediated ternary complexes. J. Chem. Inf. Model. 60, 4894\u20134903 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR46","doi-asserted-by":"publisher","unstructured":"Paggi, J. M. et al. Leveraging nonstructural data to predict structures and affinities of protein-ligand complexes. Proc. Natl Acad. Sci. U. S. A. https:\/\/doi.org\/10.1073\/pnas.2112621118 (2021).","DOI":"10.1073\/pnas.2112621118"},{"key":"527_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/s42256-020-0152-y","volume":"2","author":"S Zheng","year":"2020","unstructured":"Zheng, S., Li, Y., Chen, S., Xu, J. & Yang, Y. Predicting drug\u2013protein interaction using quasi-visual question answering system. Nat. Mach. Intell. 2, 134\u2013140 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"527_CR48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cbpa.2019.02.022","volume":"50","author":"SL Paiva","year":"2019","unstructured":"Paiva, S. L. & Crews, C. M. Targeted protein degradation: elements of PROTAC design. Curr. Opin. Chem. Biol. 50, 111\u2013119 (2019).","journal-title":"Curr. Opin. Chem. Biol."},{"key":"527_CR49","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1021\/acs.jmedchem.9b01566","volume":"63","author":"M Cheng","year":"2020","unstructured":"Cheng, M. et al. Discovery of potent and selective epidermal growth factor receptor (EGFR) bifunctional small-molecule degraders. J. Med. Chem. 63, 1216\u20131232 (2020).","journal-title":"J. Med. Chem."},{"key":"527_CR50","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1021\/acs.jcim.0c01344","volume":"61","author":"J Jimenez-Luna","year":"2021","unstructured":"Jimenez-Luna, J., Skalic, M., Weskamp, N. & Schneider, G. Coloring molecules with explainable artificial intelligence for preclinical relevance assessment. J. Chem. Inf. Model. 61, 1083\u20131094 (2021).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR51","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1126\/science.abj8754","volume":"373","author":"M Baek","year":"2021","unstructured":"Baek, M. et al. Accurate prediction of protein structures and interactions using a three-track neural network. Science 373, 871\u2013876 (2021).","journal-title":"Science"},{"key":"527_CR52","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"527_CR53","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15\u2013ligand discovery for everyone. J. Chem. Inf. Model. 55, 2324\u20132337 (2015).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR54","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3390\/molecules26030672","volume":"26","author":"G Ermondi","year":"2021","unstructured":"Ermondi, G., Garcia-Jimenez, D. & Caron, G. PROTACs and building blocks: the 2D chemical space in very early drug discovery. Molecules 26, 672 (2021).","journal-title":"Molecules"},{"key":"527_CR55","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1021\/ci900450m","volume":"50","author":"J Hussain","year":"2010","unstructured":"Hussain, J. & Rea, C. Computationally efficient algorithm to identify matched molecular pairs (MMPs) in large data sets. J. Chem. Inf. Model. 50, 339\u2013348 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"527_CR56","unstructured":"Nair, V. & Hinton, G. E. Rectified Linear Units Improve Restricted Boltzmann Machines. In Furnkranz, J. and Joachims, T. (eds) Proceedings of the 27th International Conference on Machine Learning, 807-814, (2010). https:\/\/icml.cc\/Conferences\/2010\/papers\/432.pdf"},{"key":"527_CR57","unstructured":"Ba, J. L., Kiros, J. R. & Hinton, G. E. Layer normalization. Preprint at https:\/\/arxiv.org\/abs\/1607.06450 (2016)."},{"key":"527_CR58","doi-asserted-by":"crossref","unstructured":"He, K., Zhang, X., Ren, S. & Sun, J. Deep Residual Learning for Image Recognition. In Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, Computer Society, 770\u2013778 (2016).","DOI":"10.1109\/CVPR.2016.90"},{"key":"527_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13321-017-0235-x","volume":"9","author":"M Olivecrona","year":"2017","unstructured":"Olivecrona, M., Blaschke, T., Engkvist, O. & Chen, H. Molecular de-novo design through deep reinforcement learning. J. Cheminform. 9, 1\u201314 (2017).","journal-title":"J. Cheminform."},{"key":"527_CR60","doi-asserted-by":"publisher","first-page":"8683","DOI":"10.1021\/acs.jmedchem.9b02147","volume":"63","author":"C Cai","year":"2020","unstructured":"Cai, C. et al. Transfer learning for drug discovery. J. Med. Chem. 63, 8683\u20138694 (2020).","journal-title":"J. Med. Chem."},{"key":"527_CR61","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.chembiol.2017.09.009","volume":"25","author":"GM Burslem","year":"2018","unstructured":"Burslem, G. M. et al. The advantages of targeted protein degradation over inhibition: an RTK case study. Cell Chem. Biol. 25, 67\u201377. e63 (2018).","journal-title":"Cell Chem. Biol."},{"key":"527_CR62","doi-asserted-by":"publisher","first-page":"11615","DOI":"10.1021\/acs.jmedchem.0c00793","volume":"63","author":"L Goracci","year":"2020","unstructured":"Goracci, L. et al. Understanding the metabolism of proteolysis targeting chimeras (PROTACs): the next step toward pharmaceutical applications. J. Med. Chem. 63, 11615\u201311638 (2020).","journal-title":"J. Med. Chem."},{"key":"527_CR63","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1016\/S0928-0987(00)00181-0","volume":"11","author":"JB Dressman","year":"2000","unstructured":"Dressman, J. B. & Reppas, C. In vitro\u2013in vivo correlations for lipophilic, poorly water-soluble drugs. Eur. J. Pharm. Sci. 11, S73\u2013S80 (2000).","journal-title":"Eur. J. Pharm. Sci."},{"key":"527_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","volume":"23","author":"CA Lipinski","year":"1997","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3\u201325 (1997).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"527_CR65","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615\u20132623 (2002).","journal-title":"J. Med. Chem."},{"key":"527_CR66","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1021\/acs.jmedchem.7b00717","volume":"61","author":"DA DeGoey","year":"2017","unstructured":"DeGoey, D. A., Chen, H.-J., Cox, P. B. & Wendt, M. D. Beyond the rule of 5: lessons learned from AbbVie\u2019s drugs and compound collection: miniperspective. J. Med. Chem. 61, 2636\u20132651 (2017).","journal-title":"J. Med. Chem."},{"key":"527_CR67","doi-asserted-by":"publisher","first-page":"W363","DOI":"10.1093\/nar\/gki481","volume":"33","author":"D Schneidman-Duhovny","year":"2005","unstructured":"Schneidman-Duhovny, D., Inbar, Y., Nussinov, R. & Wolfson, H. J. PatchDock and SymmDock: servers for rigid and symmetric docking. Nucleic Acids Res. 33, W363\u2013W367 (2005).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Machine Intelligence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42256-022-00527-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-022-00527-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42256-022-00527-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T20:17:17Z","timestamp":1668802637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42256-022-00527-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":67,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["527"],"URL":"https:\/\/doi.org\/10.1038\/s42256-022-00527-y","relation":{},"ISSN":["2522-5839"],"issn-type":[{"value":"2522-5839","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"21 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.Z., Z.W., C.L., Z.Z. and X.S. work directly or indirectly for Galixir. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}